SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Labwire Inc.
LBWR 0.00010000.0%Oct 24 3:23 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Sidney Reilly8/26/2008 12:38:40 PM
   of 1698
 
From the 10-12g...Labwire has a competitive edge in the industry.

Competition

Testing for drug use and abuse has evolved at a dramatic rate from a small minority of companies testing employees for substance abuse in the mid-1980s to the practice becoming standard in almost all government agencies and large corporate firms in the 1990s. Legislation requiring the testing of all transportation industry workers, as well as court decisions upholding the legality of testing high school students, is making drug testing commonplace in all segments of society. Overall, the drugs of abuse market was projected to witness average annual growth of about 4.7% from 2002 to 2007 [Business Communications Company – July 2002]. Labwire’s principals have provided client oriented “service philosophy” substance abuse management services for the past 21 years. The Labwire operating platform, which provides modular delivery systems, procedures compliant with HIPAA protocols (unique within the industry), and live user-friendly access to all clients, all while adhering to ISO 9000:2000 certification standards (also unique within the industry). Labwire specifically addresses the concerns generated by the growing “commodity philosophy” currently prevalent within the industry. With the recent acquisition of traditional TPA’s by corporate entities not previously involved in substance abuse management, the need for a return to a service based philosophy is apparent. Labwire’s experienced staff and compliant platform are ready to provide its clients with “Great Service … Period.”

Labwire’s methods of marketing in this competitive industry consists of traditional marketing ventures, including direct mail campaigns, selective media advertising, and participation in targeted conferences and trade shows. In addition, Labwire is uniquely able to draw upon the extensive experience of its management to capitalize on personal contacts with key industry players and deliver a quick response at critical times. Labwire believes that it has competitive advantages over its competitors with its Labwire™ Platform, which is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. All the data is on one page and the software is very easy to learn and use. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry and the only one that is currently compliant with HIPPA regulations. The industry average is approximately $175,000 in revenue per employee, while Labwire’s approximately $million per employee.

Labwire also has joint marketing ventures with key suppliers which allow it access to large companies across the country.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext